Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMRV Vaccine (AMP) vs 2006 Process in Children
NCT01536405Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2012
- Primary completion
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of varicella virus vaccine live new seed process + measles, mumps, and rubella virus vaccine live in measles, mumps, rubella, varicella (VZV), sponsored by Merck & Co.. Started Jun 2012; status: completed.
02
Drugs
varicella virus vaccine live new seed process + measles, mumps, and rubella virus vaccine live
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT01536405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01536405.